EMQN join DEVOTE programme

EMQN CIC are delighted to be part of the DEVOTE programme, working with the partners (genedrive, Chromition, APIS Assay Technologies Ltd., Manchester University NHS Foundation Trust, Health Innovation Manchester) to deliver EQA for point-of-care testing in pharmacogenetics. Ensuring the delivery of high quality testing to support personalised treatment at the right time to improve patient outcomes.